Align Technology, Inc.

ALGN Healthcare Medical Instruments & Supplies

Align Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 0.90% from fiscal 2024.

Revenue
+1.92%
EPS
+143.9%
Free cash flow
+8.26%

Quarter to September 2026, against a year earlier

164.08 4.71 +2.96%
Market cap
$11.3B
P/E
23.1×
Fwd P/E
20.4×
Dividend yield
—
F-score
6/9
Altman Z
4.73
Beneish M
−2.52
Dividend safety
n/a

Align Technology, Inc. 8-K filed Nov 6, 2026

Period ended Nov 5, 2026 · Filed · accepted 9:13 PM ET · Document on sec.gov · Filing index

1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits

What it says

On November 5, 2026, Align Technology entered an agreement with Goldman Sachs & Co. LLC to repurchase $270 million of common stock under its $1.0 billion repurchase program. Align will prepay $270 million and initially receive approximately 1.44 million shares. The final share count depends generally on the average daily volume-weighted average price, less a discount. Final settlement is expected no later than approximately December 29, 2026.

  • At settlement, Goldman Sachs may owe Align additional shares, or Align may owe Goldman Sachs shares or cash.

    Goldman Sachs may be required to deliver additional shares of common stock to the Company, or under certain circumstances, the Company may be required either to deliver shares of common stock or to make a cash payment to Goldman Sachs. — the 8-K
  • Align will fund the transaction with cash on hand. It expects approximately $330 million to remain available under the program afterward.

    Following the $270 million ASR, Align expects approximately $330 million to remain available for future repurchases under the $1.0 billion stock repurchase program. — the exhibit filed with it
  • The transaction is expected to bring Align’s total 2026 share repurchases to approximately $500 million.

    This $270 million accelerated stock repurchase fulfills the share repurchase commitment we announced in July and is expected to bring our total 2026 share repurchases to approximately $500 million, — the exhibit filed with it